Group 1 - A significant drop in stock prices of several Chinese micro-cap stocks listed in the US has resulted in investors losing billions of dollars, raising concerns about a potential "pump and dump" scheme [1] - Seven specific stocks, including Concorde International (CIGL.US) and Austin Technology (OST.US), have seen declines exceeding 80% in recent trading days, leading to a total market value loss of $3.7 billion [1] - Prior to the sharp declines, these stocks had experienced substantial increases and were promoted on social media platforms like WhatsApp [1] Group 2 - Brain Regen Technologies (RGC.US) has seen its stock price increase nearly 10,000% this year, with no current evidence linking the company to stock price fluctuations [2] - The FBI reported a 300% increase in complaints related to "pump and dump" stock fraud over the past year, indicating a rise in investor victimization [2] - Fraud groups are reportedly using social media ads and "investment club" promotions to lure investors, sometimes impersonating legitimate brokerage firms or well-known stock analysts [2]

Core Insights - Park Ha (PHH) opened with a significant increase of 24.45%, reaching a stock price of $0.82 per share, with a trading volume of $1.3684 million and a total market capitalization of $21.6244 million [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.3819 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic entity, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand specializes in providing solutions for problematic skin, established in 2016, with its first store opening in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, compared to 49 franchisees in 2022 [1] - Among these, 41, 36, and 45 franchisees operated under the "Park Ha" brand name in the respective years [1]

Group 1 - The top five gaining Chinese concept stocks at the close were Lichen International, ATA Creativity Global, Huami Technology, Puhua Biotechnology, and Feitian Zhaoye, with respective gains of 48.81%, 36.11%, 34%, 24.45%, and 23.46% [1] - Lichen International's latest price was 5.610, with a gain of 1.840 and a trading volume of 14.39 million [1] - ATA Creativity Global's latest price was 1.470, with a gain of 0.390 and a trading volume of 7.29 million [1] Group 2 - Huami Technology's latest price was 17.420, with a gain of 4.420 and a trading volume of 22.89 million [1] - Puhua Biotechnology's latest price was 0.8199, with a gain of 0.1611 and a trading volume of 1.36 million [1] - Feitian Zhaoye's latest price was 1.0000, with a gain of 0.1900 and a trading volume of 16.93 million [1]

Core Viewpoint - Park Ha (PHH) experienced a significant stock price increase of 17.76%, reaching $0.776 per share, with a total market capitalization of $20.46 million as of August 5 [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.38 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand, established in 2016, aims to provide solutions for problematic skin and opened its first store in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, with 41 and 36 operating under the "Park Ha" name [1] - In 2022, the company had a total of 49 franchisees [1]

作者：行情君 本文源自：金融界 7月30日，朴荷(PHH)盘中上涨2.94%，截至22:12，报0.788美元/股，成交10.17万美元，总市值2076.98 万美元。 财务数据显示，截至2024年10月31日，朴荷收入总额238.19万人民币，同比减少3.14%；归母净利润 47.86万人民币，同比减少43.83%。 资料显示，朴荷生物科技有限公司是一家在开曼群岛注册成立的境外控股母公司,主要由其境内实体子 公司江苏朴荷生物科技有限公司运营。公司业务主要包括开发自有护肤品牌、直销护肤品及特许加盟联 盟推广。其"Park Ha"品牌专注于为问题皮肤提供解决方案。该品牌成立于2016年,2017年开设了第一家 门店。除了江苏朴荷直接经营的两家门店外,截至2024年4月30日、2023年10月31日和2022年,该公司在中 国拥有43家、38家和49家加盟商,其中41家、36家和45家加盟商以"朴荷"店名经营。 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report For the transition period from ____________ to ____________ OR ☒ ANNUAL REPORT PUR ...